A critical breakthrough in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently lost in many forms of tumors, causing https://sound-social.com/story12301697/mini-antibodies-revive-the-p53-protein-new-new-approach-for-malignant-therapy